1. Home
  2. Analysis
  3. Enovid

Enovid side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Enovid. Common side effects include acanthoma among females.

The phase IV clinical study is created by eHealthMe based on 8 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 02, 2023

8 people who take Enovid and have side effects are studied.

What is Enovid?

Enovid has active ingredients of mestranol; norethynodrel. eHealthMe is studying from 12 Enovid users for its effectiveness, alternative drugs and more.

Number of Enovid reports submitted per year:

Enovid side effects.

Enovid side effects by time on the drug*:

< 1 month:

n/a

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Acanthoma (a skin cancer)
  2. Breast atrophy (overly enlarged breasts)
  3. Breast cancer
  4. Breast cancer in situ

Enovid side effects by gender *:

female:

  1. Acanthoma (a skin cancer)
  2. Breast atrophy (overly enlarged breasts)
  3. Breast cancer
  4. Breast cancer in situ

male:

n/a

Enovid side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Acanthoma (a skin cancer)

50-59:

n/a

60+:

  1. Breast cancer
  2. Breast cancer in situ

* Approximation only. Some reports may have incomplete information.

Do you take Enovid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on mestranol; norethynodrel (the active ingredients of Enovid) and Enovid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Enovid:

All Enovid side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.